Immunogenicity and Efficacy of a Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Against HSV-1 Eye Infection and Neuroinvasion in MiceAlyssa Chalmin Katz, Harvey M. Friedman, Kevin P. Egan et al.|Vaccines|2026Cited by 0